Sellas vaccine extends survival in blood cancer trial, shares surge
Summary
Sellas vaccine extends survival in blood cancer trial, shares surge Reuters
Description from Reuters.
Who is covering this
-
Sellas vaccine extends survival in blood cancer trial, shares surge - Reuters
Sellas vaccine extends survival in blood cancer trial, shares surge Reuters
-
Sellas' Vaccine Extends Survival in Blood Cancer Trial
Drug developer Sellas Life Sciences said on Tuesday its experimental vaccine for a type of blood cancer helped patients live significantly longer in a late-stage... Reuters Health Information


Comments
Comments need JavaScript.